<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Epidemiology, risk factors, and etiology of hypertension in children and adolescents</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Epidemiology, risk factors, and etiology of hypertension in children and adolescents</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Epidemiology, risk factors, and etiology of hypertension in children and adolescents</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Tej K Mattoo, MD, DCH, FRCP</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">F Bruder Stapleton, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alison G Hoppin, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 18, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Hypertension (HTN) begins in childhood and adolescence and contributes to the early development of cardiovascular disease in adult life. The supporting data include clinical studies that demonstrate cardiovascular structural and functional changes in children with HTN and autopsy studies that have shown an association of blood pressure (BP) with atherosclerotic changes in the aorta and heart in children and young adults. In hypertensive adults, multiple randomized trials have shown that reduction of BP by antihypertensive therapy reduces cardiovascular morbidity and mortality. The magnitude of the benefit increases with the severity of the HTN. (See  <a class="medical medical_review" href="/d/html/3852.html" rel="external">"Overview of hypertension in adults"</a>.)</p><p>Based on these observations, identifying and successfully treating HTN in children is likely to have an important impact on long-term outcomes of cardiovascular disease.</p><p>The epidemiology, risk factors, and etiology of childhood HTN will be reviewed here. Related content can be found in the following topic reviews:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/6087.html" rel="external">"Definition and diagnosis of hypertension in children and adolescents"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/6088.html" rel="external">"Evaluation of hypertension in children and adolescents"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5781.html" rel="external">"Overview of risk factors for development of atherosclerosis and early cardiovascular disease in childhood", section on 'Hypertension'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/6131.html" rel="external">"Nonemergent treatment of hypertension in children and adolescents"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5001.html" rel="external">"Etiology, clinical features, and diagnosis of neonatal hypertension"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">DEFINITIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypertension (HTN)</strong> – For children in the United States, the <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fpediatrics.aappublications.org%2Fcontent%2Fearly%2F2017%2F08%2F21%2Fpeds.2017-1904.full&amp;token=cg%2FUCQM33sNQy%2BqXTCKCRj231mK0UhmBjFaG%2FFus86bpXmQ0ED%2BDx48mhvHjhlvlcKiOK4XFwdLpYMoeW7y0%2F%2BPVC%2FdafYbo15HpJVqqfi6m3Y3dL692YBN%2B9tlL9%2B9R&amp;TOPIC_ID=6111" target="_blank">2017 American Academy of Pediatrics (AAP) guidelines</a> for screening and managing high blood pressure (BP) for children and adolescents definitions are used to categorize BP for two different age groups  (<a class="graphic graphic_table graphicRef114574" href="/d/graphic/114574.html" rel="external">table 1</a>) [<a href="#rid1">1</a>]. BP percentiles are based on sex, age, and height  (<a class="graphic graphic_table graphicRef63856" href="/d/graphic/63856.html" rel="external">table 2</a> and <a class="graphic graphic_table graphicRef52646" href="/d/graphic/52646.html" rel="external">table 3</a>).</p><p></p><p class="bulletIndent1">Further details, including definitions of HTN used outside of the United States, are discussed in a separate topic review. (See  <a class="medical medical_review" href="/d/html/6087.html" rel="external">"Definition and diagnosis of hypertension in children and adolescents", section on 'Definitions'</a>.)</p><p></p><p class="bulletIndent1">Childhood HTN is divided into two categories, depending on whether or not an underlying cause can be identified  (<a class="graphic graphic_table graphicRef101809" href="/d/graphic/101809.html" rel="external">table 4</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Primary HTN – No identifiable cause is found</p><p class="bulletIndent2"><span class="glyph">•</span>Secondary HTN – An underlying cause is identified</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other categories</strong> – Other classifications of BP are based on ambulatory BP monitoring [<a href="#rid2">2</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>White coat hypertension</strong> – White coat or isolated office HTN is defined as office BP readings ≥95<sup>th</sup> percentile but with normal values outside of the clinical setting. Studies suggest a prevalence as high as one-third to one-half of children being evaluated for persistently elevated, casual BP [<a href="#rid3">3,4</a>].</p><p></p><p class="bulletIndent2">It is possible that white coat HTN in children represents two populations: one that is destined to develop primary HTN (prehypertensive) [<a href="#rid5">5,6</a>], and one that remains normotensive outside of the clinical setting. In adults, white coat HTN appears to be a prehypertensive condition with increased left ventricular mass and progression to sustained HTN. Limited data in children also suggest that some children with white coat HTN progress to ambulatory HTN. (See  <a class="medical medical_review" href="/d/html/6124.html" rel="external">"Ambulatory blood pressure monitoring in children", section on 'White coat hypertension'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Masked hypertension</strong> – Masked HTN is characterized by normal BP in clinic or office and a high ambulatory BP outside of the office, including home. Masked HTN is associated with obesity and increased left ventricular mass, which are risk factors for early adult cardiovascular disease [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/d/html/6124.html" rel="external">"Ambulatory blood pressure monitoring in children", section on 'Masked hypertension'</a>.)</p><p></p><p class="bulletIndent1">Patient selection for ambulatory BP monitoring, interpretation of the results, and clinical implications of these diagnoses are discussed separately. (see  <a class="medical medical_review" href="/d/html/6124.html" rel="external">"Ambulatory blood pressure monitoring in children", section on 'Classification of blood pressure'</a>)</p><p></p><p class="headingAnchor" id="H3"><span class="h1">EPIDEMIOLOGY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevalence</strong> – In the United States, the prevalence of HTN in children and adolescents is approximately 4 percent, using criteria defined by the 2017 American Academy of Pediatrics (AAP) guideline [<a href="#rid7">7,8</a>]. A similar prevalence for pediatric HTN was noted by a systematic review and meta-analysis of studies conducted in many different countries and regions, including both rural and urban populations [<a href="#rid9">9</a>]. This study used a strict definition of HTN, based on blood pressure (BP) measurements conducted at least on three separate occasions in individuals up to 19 years of age. It did not use the definition from the 2017 AAP guidelines, which may have resulted in a higher prevalence.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Impact of choice of definition</strong> – The risk of elevated BP and HTN depends on the definition used to categorize BP. Several studies reported higher rates of elevated BP and HTN when the BP definitions in the 2017 AAP guidelines were used compared with an earlier definition (Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents) or the 2016 European Society of Hypertension guidelines [<a href="#rid7">7,10-16</a>]. As a result, use of the 2017 AAP guidelines identifies more children with elevated BP and HTN who will require additional follow-up and possibly treatment. Of note, males and individuals who with overweight or obesity were more likely to be reclassified with a higher category of BP (ie, elevated BP or HTN) [<a href="#rid7">7,10,12</a>]. These findings were confirmed by a prospective study that reported that the prevalence of HTN was higher when using the 2017 guidelines compared with the previous guideline of the Fourth Report in a high-risk population of adolescents with obesity and type 2 diabetes (13 versus 8 percent, respectively) [<a href="#rid17">17</a>].</p><p></p><p class="headingAnchor" id="H4"><span class="h1">RISK FACTORS FOR PRIMARY HYPERTENSION</span><span class="headingEndMark"> — </span>Risk factors for primary HTN can be separated into modifiable and nonmodifiable factors.</p><p class="headingAnchor" id="H473645309"><span class="h2">Modifiable risk factors</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Obesity</strong> – There are strong observational data linking the risk of HTN to excess body weight in school-aged children [<a href="#rid18">18-23</a>]. By contrast, a report from the Bogalusa Heart Study showed that mean systolic and diastolic blood pressure (BP) levels did not increase, despite a rise in the prevalence of obesity from 6 to 17 percent over the study period from 1974 to 1993 [<a href="#rid24">24</a>]. Nevertheless, within this cohort of 11,478 children, there was a positive correlation of body mass index (BMI) and BP levels. However, these results suggest that other factors may have ameliorated the expected increase in BP due to the increasing prevalence of obesity. (See  <a class="medical medical_review" href="/d/html/5874.html" rel="external">"Definition, epidemiology, and etiology of obesity in children and adolescents"</a> and  <a class="medical medical_review" href="/d/html/5869.html" rel="external">"Overview of the health consequences of obesity in children and adolescents"</a>.)</p><p></p><p class="bulletIndent1">The relationship between elevated BP and weight appears to begin in early childhood. In a retrospective review of primary care visits of 18,618 children between 2 and 19 years of age, systolic and diastolic BP increased with increasing BMI in all age groups, including children between two and five years of age [<a href="#rid25">25</a>]. In a longitudinal study, systolic BP and weight-for-length were measured in 530 children from birth to three years of age [<a href="#rid26">26</a>]. An increase in the weight-for-length in the first six months of life was associated with higher systolic BP at three years of life, particularly among infants who were thin at birth. In another longitudinal study, weight gain during infancy and early childhood was the predominant predictor of HTN at age five years, whereas current weight status was the predominant predictor at age 10 years [<a href="#rid27">27</a>].</p><p></p><p class="bulletIndent1">The metabolic syndrome is a clustering of conditions that include obesity, high BP, insulin resistance, abnormal glucose tolerance, and abnormal lipid levels. The association of abnormal lipids with BP was shown in a retrospective, case-control study of 497 patients 2 to 18 years of age that found that significantly more boys with high BP had low high-density lipoprotein cholesterol compared with boys with normal BP (49.4 versus 27.6 percent, respectively) [<a href="#rid28">28</a>]. (See  <a class="medical medical_review" href="/d/html/1784.html" rel="external">"Metabolic syndrome (insulin resistance syndrome or syndrome X)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dietary sodium intake</strong> – Observational data have shown that BP levels in children increase with higher sodium intake. In a population-based study in the United States, the risk for elevated systolic BP was higher in children with an elevated sodium intake (defined as &gt;1.5 times reference daily intake) compared with those with a lower sodium intake (odds ratio [OR] 1.36, 95% CI 1.04-1.77) after controlling for both overall and central obesity [<a href="#rid19">19</a>]. In a meta-analysis of children with elevated BP, systolic BP increased by 6.3 mmHg (95% CI 2.9-9.6) and diastolic BP increased by 3.5 mmHg (95% CI 1.2-5.7) for every additional gram of sodium intake [<a href="#rid29">29</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Obstructive sleep apnea (OSA)</strong> – OSA, which causes intermittent partial or complete occlusion of the upper airway during sleep, is a risk factor for increased BP, independent of obesity [<a href="#rid30">30,31</a>]. (See  <a class="medical medical_review" href="/d/html/97874.html" rel="external">"Cardiovascular consequences of obstructive sleep apnea in children", section on 'Changes in blood pressure'</a>.)</p><p></p><p class="bulletIndent1">One observational study reported that improvement in sleep-disordered breathing was associated with improved BP control [<a href="#rid32">32</a>]. Similarly, adenotonsillectomy for OSA in children modestly reduces BP [<a href="#rid33">33,34</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physical activity</strong> – Studies of the relationship between physical activity during childhood and HTN risk reach mixed conclusions. A large meta-analysis found a modest beneficial effect of physical activity on BP and other cardiovascular risk factors [<a href="#rid35">35</a>]. A separate review concluded that regular physical activity reduces BP by approximately 2 mmHg [<a href="#rid36">36</a>]. Physical activity may also contribute to weight control. In a meta-analysis, aerobic exercise improved BP, body weight, and other components of the metabolic syndrome [<a href="#rid37">37</a>]. (See  <a class="medical medical_review" href="/d/html/16975.html" rel="external">"Pediatric prevention of adult cardiovascular disease: Promoting a healthy lifestyle and identifying at-risk children", section on 'Physical activity'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Breastfeeding</strong> <strong>(protective)</strong> – There are reports that breastfeeding is associated with lower BPs in childhood, as illustrated by two prospective cohort studies [<a href="#rid38">38-40</a>]. (See  <a class="medical medical_review" href="/d/html/5013.html" rel="external">"Infant benefits of breastfeeding", section on 'Limited evidence for benefit'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In the first study, 7276 infants were evaluated at 7.5 years of age [<a href="#rid38">38</a>]. Those who were breastfed as infants had systolic and diastolic BPs that were 1.2 mmHg and 0.9 mmHg lower than in infants who were never breastfed. The reduction in both systolic and diastolic pressures was greater in infants who were exclusively breastfed, and the systolic BP reduction increased with the duration of breastfeeding.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Similar findings were found in 7223 singleton infants evaluated at five years of age [<a href="#rid40">40</a>]. Those who were breastfed for six months had systolic BP that was 1.2 mmHg lower than in infants who had been breastfed less than six months or not at all [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Tobacco exposure</strong> – Both active and passive tobacco exposure appears to increase BP. This was illustrated by a multivariate analysis of data from the 2007 to 2016 National Health and Nutrition Examination Survey (NHANES) of 8520 children (mean age 13.1 years), which reported that children exposed to tobacco (either active or passive) were more likely to have elevated BP compared with those without tobacco exposure, after adjustment for potential confounders (OR 1.31, 95% CI 1.06-1.61) [<a href="#rid41">41</a>]. (See  <a class="medical medical_review" href="/d/html/14583.html" rel="external">"Prevention of smoking and vaping initiation in children and adolescents"</a> and  <a class="medical medical_review" href="/d/html/6375.html" rel="external">"Secondhand smoke exposure: Effects in children", section on 'Cardiovascular disease'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Childhood adversity</strong> – Adverse childhood experiences (ACEs) describe traumatic events of childhood, including abuse, neglect, parental mental health problems, and household dysfunction, and are associated with increased mortality and morbidity throughout the life course. Observational data have linked ACEs to increased risk of overweight and obesity, cardiovascular disease (coronary heart disease and stroke), and HTN [<a href="#rid42">42-44</a>]. A systematic review reported a consistent positive correlation between violence experienced during childhood and cardiovascular outcomes, including HTN [<a href="#rid43">43</a>]. Another study found that individuals with multiple ACE exposures had more rapid increases in systolic and diastolic BP after age 30 compared with those with fewer ACE exposures [<a href="#rid44">44</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prenatal and neonatal factors</strong> – There is increasing evidence that prenatal and neonatal factors contribute to higher BP [<a href="#rid45">45,46</a>]. The possible role of low birth weight in the development of primary HTN is discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/3853.html" rel="external">"Possible role of low birth weight in the pathogenesis of primary (essential) hypertension"</a>.)</p><p></p><p class="bulletIndent1">In addition, a systematic review reported that in utero exposure to preeclampsia was associated with an increase in systolic (mean 2.4 mmHg) and diastolic (mean 1.4 mmHg) BP, as well as an increase in BMI (mean 0.62 kg/m<sup>2</sup>) [<a href="#rid47">47</a>].</p><p></p><p class="bulletIndent1">However, for children with chronic kidney disease, there appears to be no additional effect of an abnormal birth history on BP. This was illustrated in a report from the Chronic Kidney Disease in Children Study, which found no difference in BP or the rate of chronic kidney disease progression between patients with an abnormal birth history (birth weight &lt;2500 g, gestational age &lt;36 weeks, or small for gestational age) and those with a normal birth history [<a href="#rid48">48</a>].</p><p></p><p class="headingAnchor" id="H2846965149"><span class="h2">Nonmodifiable risk factors</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sex</strong> – In the United States and Canada, the prevalence of HTN and prehypertension is greater in boys than in girls [<a href="#rid18">18,22</a>]. In a Canadian cohort study of adolescents, boys were more likely to have high systolic BP (&gt;90<sup>th</sup> percentile) compared with girls in 7<sup>th</sup> (OR 1.29, 95% CI 0.77-2.16), 9<sup>th</sup> (OR 1.98, 95% CI 1.35-2.93), and 11<sup>th</sup> grades (OR 2.74, 95% CI 1.52-4.94).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Family history</strong> – A family history of HTN is present in as many as 70 to 80 percent of all patients with primary HTN (also referred to as essential HTN), which has no identifiable underlying etiology, and in approximately 50 percent of hypertensive children [<a href="#rid49">49</a>]. In particular, early-onset (age &lt;45 years) and not late-onset parental HTN (≥65 years) is associated with HTN in offspring [<a href="#rid50">50</a>].</p><p></p><p class="bulletIndent1">In patients with primary HTN, elevated BP is thought to result from the interaction of multiple genes and environmental factors. It has been estimated that genetic factors account for approximately 30 percent of the variation in BP in various populations [<a href="#rid51">51,52</a>] and as much as 60 to 70 percent of HTN in families [<a href="#rid53">53</a>]. (See  <a class="medical medical_review" href="/d/html/3847.html" rel="external">"Genetic factors in the pathogenesis of hypertension"</a>.)</p><p></p><p class="bulletIndent1">The best evidence for genetic factors influencing BP values comes from BP correlations within families:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The BP correlation is stronger between parents and children than between spouses [<a href="#rid54">54</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>There is no significant BP correlation between parents and adopted children [<a href="#rid55">55,56</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Most studies in twins have shown that BP correlation is stronger between identical (monozygotic) twins than between fraternal (dizygotic) twins or siblings [<a href="#rid54">54,57</a>]. However, the observation that the BP correlation is stronger among dizygotic twins than among other first-degree relatives indicates a nongenetic environmental effect [<a href="#rid58">58</a>].</p><p></p><p class="bulletIndent1">In both animal and human studies, a number of different genes have been evaluated, but their role remains uncertain in the pathogenesis of primary HTN. (See  <a class="medical medical_review" href="/d/html/3847.html" rel="external">"Genetic factors in the pathogenesis of hypertension"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Race and ethnicity</strong> – In the United States, data suggest that the prevalence of HTN is greater in Black and Hispanic children compared with White and Asian children [<a href="#rid18">18,59-61</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a study using NHANES data, the prevalence of BP ≥95<sup>th</sup> percentile (on a single occasion) was 4.6, 4.2, and 3.3 in Mexican American, Black, and White children, respectively, during the study period of 1999 to 2002 [<a href="#rid18">18</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a school-based screening program in Houston, Texas from 2000 to 2015, the rates for HTN were 3.1, 2.7, 2.6, and 1.7 percent for Hispanic, Black, White, and Asian adolescents (age 10 to 19 years), respectively [<a href="#rid61">61</a>]. However, the highest rate of HTN was in White adolescents with obesity (7.4 percent).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Of 2368 girls enrolled at the age of 9 or 10 years in the National Heart, Lung, and Blood Institute Growth and Health Study from 1986 to 1997, the overall incidence of HTN based on two clinic visits was greater in Black girls compared with White girls (5 versus 2.1 percent, respectively) when measured at annual visits through age 18 to 19 years [<a href="#rid60">60</a>]. The incidence increased to 10.5 and 3.8 percent in Black and White girls, respectively, whose BMIs were greater than the 95<sup>th</sup> percentile, and was lower in those with normal BMI (&lt;85<sup>th</sup> percentile, 3.5 versus 1.7 percent).</p><p></p><p class="bulletIndent1">Among adults in the United States, data from NHANES III showed that non-Hispanic Black Americans have a higher burden of HTN than other groups  (<a class="graphic graphic_figure graphicRef81756 graphicRef58221" href="/d/graphic/81756.html" rel="external">figure 1A-B</a>) [<a href="#rid62">62</a>]. Multiple factors that might contribute to this observed difference have been suggested. (See  <a class="medical medical_review" href="/d/html/3851.html" rel="external">"The prevalence and control of hypertension in adults", section on 'Prevalence of hypertension'</a> and  <a class="medical medical_review" href="/d/html/3855.html" rel="external">"Burden of hypertension in Black individuals"</a>.)</p><p></p><p class="headingAnchor" id="H13"><span class="h1">ETIOLOGY</span><span class="headingEndMark"> — </span>Causes of childhood HTN are separated into two classes  (<a class="graphic graphic_table graphicRef101809" href="/d/graphic/101809.html" rel="external">table 4</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Primary HTN – No underlying cause is identified. This is a diagnosis of exclusion.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Secondary HTN – An identifiable cause is determined  (<a class="graphic graphic_table graphicRef73738" href="/d/graphic/73738.html" rel="external">table 5</a>). In children with secondary HTN, the underlying disorder may be curable with complete resolution of HTN.</p><p></p><p class="headingAnchor" id="H14"><span class="h2">Primary hypertension</span><span class="headingEndMark"> — </span>As in adults, primary HTN is the most common cause for HTN in children and young adults in the United States, particularly in those older than six years with a positive family history and excessive body weight [<a href="#rid1">1,63</a>]. It is also more common in African American children.</p><p>The incidence of primary versus secondary HTN varies between countries and populations, likely due to differences in risk factors, referral patterns, and/or evaluation processes. (See <a class="local">'Risk factors for primary hypertension'</a> above.)</p><p class="headingAnchor" id="H15"><span class="h2">Secondary hypertension</span><span class="headingEndMark"> — </span>There are a number of causes of secondary HTN  (<a class="graphic graphic_table graphicRef73738" href="/d/graphic/73738.html" rel="external">table 5</a>). Specific symptoms  (<a class="graphic graphic_table graphicRef76420" href="/d/graphic/76420.html" rel="external">table 6</a>) and findings  (<a class="graphic graphic_table graphicRef76824" href="/d/graphic/76824.html" rel="external">table 7</a>) may point to a particular disorder.</p><p>The prevalence of secondary versus primary HTN and the causes of secondary HTN vary, depending on the country, age of the cohort, and risk factors [<a href="#rid64">64-67</a>]. Examples of the range of diagnoses made in referral centers are:</p><p class="bulletIndent1"><span class="glyph">●</span>In a 1992 review of children with sustained HTN from Poland, 351 of 636 children (55 percent) had a known secondary cause [<a href="#rid64">64</a>]. The most common were kidney disease (68 percent) and endocrine and renovascular diseases (11 and 10 percent, respectively). Almost all children (98 percent) younger than 15 years of age had a secondary cause, whereas 75 percent of adolescents had primary HTN.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In an observational series of children with sustained HTN from the United States, 102 of 132 (77 percent) had an identified secondary cause [<a href="#rid65">65</a>]. The most common cause was kidney parenchymal or renovascular disease (67 percent), mostly glomerulonephritis (GN) or reflux nephropathy. Ten percent had secondary causes other than kidney disease.</p><p></p><p>The following sections outline different etiologies of chronic (ie, persistent) secondary HTN.</p><p class="headingAnchor" id="H3966132929"><span class="h3">Kidney disease</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Kidney parenchymal disease</strong> – A variety of intrinsic kidney disorders is associated with HTN and includes the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>GN</strong> – HTN is a manifestation of acute and chronic glomerular disorders. In children, the most common form of acute glomerular disease is poststreptococcal GN, which follows after a streptococcal infection. Immunoglobulin A (IgA) vasculitis (ie, Henoch-Schönlein purpura) can present with kidney manifestations, including HTN. In children, chronic glomerular disorders associated with elevated blood pressure (BP) include IgA nephropathy, membranoproliferative GN, or lupus nephritis. (See  <a class="medical medical_review" href="/d/html/6118.html" rel="external">"Poststreptococcal glomerulonephritis"</a> and  <a class="medical medical_review" href="/d/html/3112.html" rel="external">"IgA nephropathy: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/3056.html" rel="external">"Lupus nephritis: Diagnosis and classification"</a> and  <a class="medical medical_review" href="/d/html/3055.html" rel="external">"Membranoproliferative glomerulonephritis: Classification, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/6406.html" rel="external">"IgA vasculitis (Henoch-Schönlein purpura): Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent2">In children with GN, the most common mechanisms of HTN are volume expansion due to salt and water retention (as in acute poststreptococcal GN) and activation of the renin-angiotensin system. Other common presenting features of glomerular disorders include hematuria, oliguria, peripheral edema, and elevated serum creatinine or blood urea nitrogen. (See  <a class="medical medical_review" href="/d/html/3872.html" rel="external">"Overview of hypertension in acute and chronic kidney disease"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Parenchymal scarring</strong> – Kidney parenchymal scarring can be a sequelae of acute pyelonephritis and may be associated with vesicoureteral reflux. It is also seen in children with congenital anomalies of the kidney and urinary tract. (See  <a class="medical medical_review" href="/d/html/6094.html" rel="external">"Clinical presentation, diagnosis, and course of primary vesicoureteral reflux"</a> and  <a class="medical medical_review" href="/d/html/6097.html" rel="external">"Treatment and prognosis of Shiga toxin-producing Escherichia coli (STEC) hemolytic uremic syndrome in children", section on 'Hypertension'</a> and  <a class="medical medical_review" href="/d/html/5991.html" rel="external">"Urinary tract infections in infants older than one month and children less than two years: Acute management, imaging, and prognosis", section on 'Prognosis'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Chronic kidney disease</strong> – Chronic kidney disease of any cause can be associated with HTN because of volume expansion and other factors. In addition, children who have undergone kidney transplantation are at increased risk for HTN due to several different mechanisms, including rejection or the administration of drugs that increase BP. (See  <a class="medical medical_review" href="/d/html/6143.html" rel="external">"Kidney transplantation in children: Complications", section on 'Hypertension'</a> and <a class="local">'Drugs and toxins'</a> below and  <a class="medical medical_review" href="/d/html/128353.html" rel="external">"Chronic kidney disease in children: Complications", section on 'Hypertension'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monogenic disorders</strong> – Many monogenic causes of HTN have been identified, many of which are due to gain-of-function mutations leading to salt and water retention or an increased mineralocorticoid activity. Some of the better-known forms are:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Liddle syndrome (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F177200&amp;token=tEpDslnpc0F0kICl%2Fz7sFRpMsbswgmBJuV5MFhYv5gBT5Iy0i3WzrxNAy3dTPLck&amp;TOPIC_ID=6111" target="_blank">MIM #177200</a>), due to a gain-of-function mutation in the sodium channel gene, is associated with HTN, low plasma renin and aldosterone levels, and hypokalemia. (See  <a class="medical medical_review" href="/d/html/2371.html" rel="external">"Genetic disorders of the collecting tubule sodium channel: Liddle syndrome and pseudohypoaldosteronism type 1", section on 'Liddle syndrome'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pseudohypoaldosteronism type 2 (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F145260&amp;token=tEpDslnpc0F0kICl%2Fz7sFYR8Q1aXDxBReNYTLBTBwCStob73XnCPUSRx1GV223%2Bs&amp;TOPIC_ID=6111" target="_blank">MIM #145260</a>), also known as Gordon syndrome, is due to mutations in WNK kinases 1 and 4, which result in increased chloride reabsorption with sodium. It is characterized by HTN, hyperkalemia, normal kidney function, and low or low-normal plasma renin activity and aldosterone. (See  <a class="medical medical_review" href="/d/html/2306.html" rel="external">"Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)", section on 'Pseudohypoaldosteronism type 2 (Gordon's syndrome)'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Familial hyperaldosteronism type 1 (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F103900&amp;token=tEpDslnpc0F0kICl%2Fz7sFc8JblQ%2BgdQqT9K%2Br8tS8tjloBYr7AlHqBniWD0%2BaU7n&amp;TOPIC_ID=6111" target="_blank">MIM #103900</a>), also known as glucocorticoid-remediable aldosteronism, is a disorder in which there is a chimeric gene formed from portions of the 11-beta-hydroxylase gene and the aldosterone synthase gene, which results in adrenocorticotropic hormone, stimulating aldosterone synthesis. (See  <a class="medical medical_review" href="/d/html/122.html" rel="external">"Familial hyperaldosteronism"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F202010&amp;token=tEpDslnpc0F0kICl%2Fz7sFRq9f0MGN2Oxgakbp76u2bHmIkDTAKpODFbzXY9foHOw&amp;TOPIC_ID=6111" target="_blank">MIM #202010</a>) is a disorder that has been associated with multiple mutations of the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F610613&amp;token=tEpDslnpc0F0kICl%2Fz7sFSbCnKy1I6QPXy4E96e7Dz7nKcANu%2FKoJjf%2BXbeNO%2FG5&amp;TOPIC_ID=6111" target="_blank"><i>CYP11B1</i></a> gene. (See  <a class="medical medical_review" href="/d/html/15686.html" rel="external">"Uncommon congenital adrenal hyperplasias", section on '11-beta-hydroxylase deficiency'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Apparent mineralocorticoid excess (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F218030&amp;token=tEpDslnpc0F0kICl%2Fz7sFUX%2BOjw%2BD2C%2F8LwrbSW%2B8p2w7zNcpdRLvqSt26OcRM54&amp;TOPIC_ID=6111" target="_blank">MIM #218030</a>) arises from mutations in <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F614232&amp;token=tEpDslnpc0F0kICl%2Fz7sFSbCnKy1I6QPXy4E96e7Dz5w6lm9XExxy5MX7hCqdsp9&amp;TOPIC_ID=6111" target="_blank"><i>HSD11B2</i></a>, the gene encoding the enzyme 11-beta-hydroxysteroid dehydrogenase. The defective enzyme allows normal circulating concentrations of cortisol (which are much higher than those of aldosterone) to activate the kidney mineralocorticoid receptors, resulting in increased sodium absorption. (See  <a class="medical medical_review" href="/d/html/2346.html" rel="external">"Apparent mineralocorticoid excess syndromes (including chronic licorice ingestion)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Renovascular disease</strong> – HTN due to renovascular disease is due to a decrease in renal blood flow, resulting in increased plasma levels of renin, angiotensin, and aldosterone. Children with renovascular disease generally have stage 2 HTN [<a href="#rid68">68</a>]. (See <a class="local">'Definitions'</a> above.)</p><p></p><p class="bulletIndent1">Causes of renovascular disease in children include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Fibromuscular dysplasia</strong> – Fibromuscular dysplasia is the most common etiology of renovascular disease [<a href="#rid69">69,70</a>]. It is characterized by arterial stenosis due to a noninflammatory, nonatherosclerotic process. Most children with fibromuscular dysplasia have stenosis tortuosity of visceral arteries, including abdominal aorta along with renal artery involvement [<a href="#rid71">71</a>]. (See  <a class="medical medical_review" href="/d/html/3874.html" rel="external">"Clinical manifestations and diagnosis of fibromuscular dysplasia"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Umbilical arterial catheterization</strong> – During the newborn period, catheterization of the umbilical artery may lead to a clot in the renal artery, resulting in renal arterial injury and stenosis.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Other</strong> – Other causes of renovascular disease include neurofibromatosis, arteritis, renal artery hypoplasia, and midaortic syndrome (segmental narrowing of the proximal abdominal aorta) [<a href="#rid69">69,70,72</a>]. (See  <a class="medical medical_review" href="/d/html/2939.html" rel="external">"Neurofibromatosis type 1 (NF1): Pathogenesis, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/8238.html" rel="external">"Clinical features and diagnosis of Takayasu arteritis"</a> and  <a class="medical medical_review" href="/d/html/8245.html" rel="external">"Clinical manifestations and diagnosis of polyarteritis nodosa in adults"</a>.)</p><p></p><p class="headingAnchor" id="H19"><span class="h3">Endocrinologic disease</span><span class="headingEndMark"> — </span>Endocrinologic conditions associated with HTN include the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Catecholamine excess</strong> – Catecholamine excess that results in HTN occurs in patients with pheochromocytoma and neuroblastoma and in those who use sympathomimetic drugs, including phenylpropanolamine (over-the-counter decongestant), cocaine, amphetamines, phencyclidine, epinephrine, <a class="drug drug_pediatric" data-topicid="12701" href="/d/drug information/12701.html" rel="external">phenylephrine</a>, and <a class="drug drug_pediatric" data-topicid="12826" href="/d/drug information/12826.html" rel="external">terbutaline</a>, and the combination of a monoamine oxidase inhibitor plus ingestion of tyramine-containing foods. (See  <a class="medical medical_review" href="/d/html/5850.html" rel="external">"Pheochromocytoma and paraganglioma in children"</a> and  <a class="medical medical_review" href="/d/html/5187.html" rel="external">"Clinical presentation, diagnosis, and staging evaluation of neuroblastoma"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Corticosteroid excess</strong> – Corticosteroid excess is more commonly due to exogenous administration of glucocorticoids and rarely due to endogenous production of either glucocorticoids or mineralocorticoids. In both settings, corticosteroid excess results in HTN.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Corticosteroid excess may be seen in patients with Cushing syndrome due to hypersecretion of adrenocorticotropic hormone. (See  <a class="medical medical_review" href="/d/html/125.html" rel="external">"Causes and pathophysiology of Cushing syndrome"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Mineralocorticoid excess that results in HTN may be seen in patients with congenital adrenal hyperplasia. Other rare causes of HTN due to mineralocorticoid excess include aldosterone-secreting tumors and the monogenic disorder of glucocorticoid-remediable aldosteronism. (See  <a class="medical medical_review" href="/d/html/5813.html" rel="external">"Causes of primary adrenal insufficiency in children", section on 'Congenital adrenal hyperplasia'</a> and  <a class="medical medical_review" href="/d/html/122.html" rel="external">"Familial hyperaldosteronism"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other endocrinologic disorders</strong> – Other endocrinologic abnormalities associated with HTN include thyroid disorders (hypothyroidism and hyperthyroidism) and hypercalcemia (eg, hyperparathyroidism). (See  <a class="medical medical_review" href="/d/html/7846.html" rel="external">"Clinical manifestations of hypothyroidism", section on 'Cardiovascular system'</a> and  <a class="medical medical_review" href="/d/html/7853.html" rel="external">"Cardiovascular effects of hyperthyroidism"</a> and  <a class="medical medical_review" href="/d/html/832.html" rel="external">"Clinical manifestations of hypercalcemia", section on 'Cardiovascular'</a>.)</p><p></p><p class="headingAnchor" id="H20"><span class="h3">Cardiac disease</span><span class="headingEndMark"> — </span>Coarctation of the aorta is a well-known cause of HTN. The classic findings are HTN in the upper extremities, diminished or delayed femoral pulses, and low or unobtainable arterial BP in the lower extremities. The diagnosis is confirmed by echocardiogram. (See  <a class="medical medical_review" href="/d/html/5760.html" rel="external">"Clinical manifestations and diagnosis of coarctation of the aorta"</a>.)</p><p class="headingAnchor" id="H21"><span class="h3">Drugs and toxins</span><span class="headingEndMark"> — </span>A variety of drugs and toxins can cause chronic HTN, including the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Glucocorticoids (see  <a class="medical medical_review" href="/d/html/7988.html" rel="external">"Major adverse effects of systemic glucocorticoids", section on 'Cardiovascular effects'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Oral contraceptives (see  <a class="medical medical_review" href="/d/html/3827.html" rel="external">"Contraception: Hormonal contraception and blood pressure"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Arsenic (see  <a class="medical medical_review" href="/d/html/2778.html" rel="external">"Arsenic exposure and chronic poisoning", section on 'Cardiovascular'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_pediatric" data-topicid="13193" href="/d/drug information/13193.html" rel="external">Cyclosporine</a> and <a class="drug drug_pediatric" data-topicid="12822" href="/d/drug information/12822.html" rel="external">tacrolimus</a> (see  <a class="medical medical_review" href="/d/html/7995.html" rel="external">"Pharmacology of cyclosporine and tacrolimus", section on 'Hypertension'</a>)</p><p></p><p class="headingAnchor" id="H160668383"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/109575.html" rel="external">"Society guideline links: Hypertension in children"</a>.)</p><p class="headingAnchor" id="H22"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>The Basics (see  <a class="medical medical_basics" href="/d/html/15659.html" rel="external">"Patient education: High blood pressure in children (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/1190.html" rel="external">"Patient education: High blood pressure in children (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/d/html/1184.html" rel="external">"Patient education: High blood pressure treatment in children (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H23"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical significance</strong> ‒ Hypertension (HTN) in childhood and adolescence contributes to premature atherosclerosis and the early development of cardiovascular disease. (See <a class="local">'Introduction'</a> above and  <a class="medical medical_review" href="/d/html/5781.html" rel="external">"Overview of risk factors for development of atherosclerosis and early cardiovascular disease in childhood", section on 'Hypertension'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Modifiable risk factors</strong> ‒ Modifiable risk factors include high sodium intake, overweight or obesity, lack of breastfeeding as an infant, exposure (active or passive) to tobacco smoke, and adverse childhood events (ACEs). In addition, white coat and masked HTN appear to increase the risk of primary HTN. (See <a class="local">'Modifiable risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nonmodifiable risk factors</strong> ‒ Nonmodifiable risk factors include male sex, Black and Hispanic race, and having a positive family history for HTN. (See <a class="local">'Nonmodifiable risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology</strong> ‒ The etiology of pediatric chronic HTN is divided into two categories (see <a class="local">'Etiology'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Primary HTN, in which no underlying cause is identified.</p><p></p><p class="bulletIndent2">A family history of HTN is present in as many as 70 to 80 percent of all patients with primary HTN. In patients with primary HTN, elevated blood pressure (BP) is thought to result from the interaction of multiple genes and environmental factors. (See <a class="local">'Primary hypertension'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Secondary HTN, in which an underlying cause is identified  (<a class="graphic graphic_table graphicRef73738" href="/d/graphic/73738.html" rel="external">table 5</a>). (See <a class="local">'Secondary hypertension'</a> above.)</p><p></p><p class="bulletIndent2">The most common condition resulting in secondary HTN is kidney disease, followed by endocrine and renovascular diseases. Rarely, monogenic disorders, such as glucocorticoid-remediable aldosteronism, autosomal polycystic kidney disease, and Liddle syndrome, can cause HTN. (See <a class="local">'Secondary hypertension'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics 2017; 140.</a></li><li><a class="nounderline abstract_t">Flynn JT, Urbina EM, Brady TM, et al. Ambulatory Blood Pressure Monitoring in Children and Adolescents: 2022 Update: A Scientific Statement From the American Heart Association. Hypertension 2022; 79:e114.</a></li><li><a class="nounderline abstract_t">Ocón-Pujadas J, Mora-Maciá J. White coat hypertension and related phenomena. A clinical approach. Drugs 1993; 46 Suppl 2:95.</a></li><li><a class="nounderline abstract_t">Hanevold CD. White Coat Hypertension in Children and Adolescents. Hypertension 2019; 73:24.</a></li><li><a class="nounderline abstract_t">Matthews KA, Woodall KL, Allen MT. Cardiovascular reactivity to stress predicts future blood pressure status. Hypertension 1993; 22:479.</a></li><li><a class="nounderline abstract_t">Westerståhl M, Forss M, Persson L, et al. Hypertension outcomes and cardiovascular status in young adults with childhood-diagnosed white coat hypertension. Arch Dis Child 2018; 103:113.</a></li><li><a class="nounderline abstract_t">Jackson SL, Zhang Z, Wiltz JL, et al. Hypertension Among Youths - United States, 2001-2016. MMWR Morb Mortal Wkly Rep 2018; 67:758.</a></li><li><a class="nounderline abstract_t">Hardy ST, Sakhuja S, Jaeger BC, et al. Trends in Blood Pressure and Hypertension Among US Children and Adolescents, 1999-2018. JAMA Netw Open 2021; 4:e213917.</a></li><li><a class="nounderline abstract_t">Song P, Zhang Y, Yu J, et al. Global Prevalence of Hypertension in Children: A Systematic Review and Meta-analysis. JAMA Pediatr 2019; 173:1154.</a></li><li><a class="nounderline abstract_t">Sharma AK, Metzger DL, Rodd CJ. Prevalence and Severity of High Blood Pressure Among Children Based on the 2017 American Academy of Pediatrics Guidelines. JAMA Pediatr 2018; 172:557.</a></li><li><a class="nounderline abstract_t">Bell CS, Samuel JP, Samuels JA. Prevalence of Hypertension in Children. Hypertension 2019; 73:148.</a></li><li><a class="nounderline abstract_t">Dong Y, Song Y, Zou Z, et al. Updates to pediatric hypertension guidelines: influence on classification of high blood pressure in children and adolescents. J Hypertens 2019; 37:297.</a></li><li><a class="nounderline abstract_t">Larkins NG, Teixeira-Pinto A, Kim S, et al. The population-based prevalence of hypertension and correlates of blood pressure among Australian children. Pediatr Nephrol 2019; 34:1107.</a></li><li><a class="nounderline abstract_t">Di Bonito P, Valerio G, Pacifico L, et al. Impact of the 2017 Blood Pressure Guidelines by the American Academy of Pediatrics in overweight/obese youth. J Hypertens 2019; 37:732.</a></li><li><a class="nounderline abstract_t">Lurbe E, Torró I, Álvarez J, et al. Impact of ESH and AAP hypertension guidelines for children and adolescents on office and ambulatory blood pressure-based classifications. J Hypertens 2019; 37:2414.</a></li><li><a class="nounderline abstract_t">Yang L, Kelishadi R, Hong YM, et al. Impact of the 2017 American Academy of Pediatrics Guideline on Hypertension Prevalence Compared With the Fourth Report in an International Cohort. Hypertension 2019; 74:1343.</a></li><li><a class="nounderline abstract_t">Khoury M, Khoury PR, Dolan LM, et al. Clinical Implications of the Revised AAP Pediatric Hypertension Guidelines. Pediatrics 2018; 142.</a></li><li><a class="nounderline abstract_t">Din-Dzietham R, Liu Y, Bielo MV, Shamsa F. High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation 2007; 116:1488.</a></li><li><a class="nounderline abstract_t">Rosner B, Cook NR, Daniels S, Falkner B. Childhood blood pressure trends and risk factors for high blood pressure: the NHANES experience 1988-2008. Hypertension 2013; 62:247.</a></li><li><a class="nounderline abstract_t">Jago R, Harrell JS, McMurray RG, et al. Prevalence of abnormal lipid and blood pressure values among an ethnically diverse population of eighth-grade adolescents and screening implications. Pediatrics 2006; 117:2065.</a></li><li><a class="nounderline abstract_t">Parker ED, Sinaiko AR, Kharbanda EO, et al. Change in Weight Status and Development of Hypertension. Pediatrics 2016; 137:e20151662.</a></li><li><a class="nounderline abstract_t">Dasgupta K, O'Loughlin J, Chen S, et al. Emergence of sex differences in prevalence of high systolic blood pressure: analysis of a longitudinal adolescent cohort. Circulation 2006; 114:2663.</a></li><li><a class="nounderline abstract_t">Wirix AJ, Nauta J, Groothoff JW, et al. Is the prevalence of hypertension in overweight children overestimated? Arch Dis Child 2016; 101:998.</a></li><li><a class="nounderline abstract_t">Freedman DS, Goodman A, Contreras OA, et al. Secular trends in BMI and blood pressure among children and adolescents: the Bogalusa Heart Study. Pediatrics 2012; 130:e159.</a></li><li><a class="nounderline abstract_t">Falkner B, Gidding SS, Ramirez-Garnica G, et al. The relationship of body mass index and blood pressure in primary care pediatric patients. J Pediatr 2006; 148:195.</a></li><li><a class="nounderline abstract_t">Belfort MB, Rifas-Shiman SL, Rich-Edwards J, et al. Size at birth, infant growth, and blood pressure at three years of age. J Pediatr 2007; 151:670.</a></li><li><a class="nounderline abstract_t">Lurbe E, Aguilar F, Álvarez J, et al. Determinants of Cardiometabolic Risk Factors in the First Decade of Life: A Longitudinal Study Starting at Birth. Hypertension 2018; 71:437.</a></li><li><a class="nounderline abstract_t">Boyd GS, Koenigsberg J, Falkner B, et al. Effect of obesity and high blood pressure on plasma lipid levels in children and adolescents. Pediatrics 2005; 116:442.</a></li><li><a class="nounderline abstract_t">Rios-Leyvraz M, Bloetzer C, Chatelan A, et al. Sodium intake and blood pressure in children with clinical conditions: A systematic review with meta-analysis. J Clin Hypertens (Greenwich) 2019; 21:118.</a></li><li><a class="nounderline abstract_t">Li AM, Au CT, Ng C, et al. A 4-year prospective follow-up study of childhood OSA and its association with BP. Chest 2014; 145:1255.</a></li><li><a class="nounderline abstract_t">Baker-Smith CM, Isaiah A, Melendres MC, et al. Sleep-Disordered Breathing and Cardiovascular Disease in Children and Adolescents: A Scientific Statement From the American Heart Association. J Am Heart Assoc 2021; 10:e022427.</a></li><li><a class="nounderline abstract_t">Vlahandonis A, Yiallourou SR, Sands SA, et al. Long-term changes in blood pressure control in elementary school-aged children with sleep-disordered breathing. Sleep Med 2014; 15:83.</a></li><li><a class="nounderline abstract_t">Kuo YL, Kang KT, Chiu SN, et al. Blood pressure after surgery among obese and nonobese children with obstructive sleep apnea. Otolaryngol Head Neck Surg 2015; 152:931.</a></li><li><a class="nounderline abstract_t">Kang KT, Chiu SN, Lin CY, et al. Effect of Adenotonsillectomy on Ambulatory Blood Pressure in Pediatric Obstructive Sleep Apnea: 6-Month Follow-up Study. Otolaryngol Head Neck Surg 2019; 160:911.</a></li><li><a class="nounderline abstract_t">Ekelund U, Luan J, Sherar LB, et al. Moderate to vigorous physical activity and sedentary time and cardiometabolic risk factors in children and adolescents. JAMA 2012; 307:704.</a></li><li><a class="nounderline abstract_t">Falkner B, Gidding SS, Baker-Smith CM, et al. Pediatric Primary Hypertension: An Underrecognized Condition: A Scientific Statement From the American Heart Association. Hypertension 2023; 80:e101.</a></li><li><a class="nounderline abstract_t">Cao Y, Zhu L, Liu J. Effects of aerobic exercise on obese children with metabolic syndrome: a systematic review and meta-analysis. J Pediatr Endocrinol Metab 2021; 34:1069.</a></li><li><a class="nounderline abstract_t">Martin RM, Ness AR, Gunnell D, et al. Does breast-feeding in infancy lower blood pressure in childhood? The Avon Longitudinal Study of Parents and Children (ALSPAC). Circulation 2004; 109:1259.</a></li><li><a class="nounderline abstract_t">Wilson AC, Forsyth JS, Greene SA, et al. Relation of infant diet to childhood health: seven year follow up of cohort of children in Dundee infant feeding study. BMJ 1998; 316:21.</a></li><li><a class="nounderline abstract_t">Lawlor DA, Najman JM, Sterne J, et al. Associations of parental, birth, and early life characteristics with systolic blood pressure at 5 years of age: findings from the Mater-University study of pregnancy and its outcomes. Circulation 2004; 110:2417.</a></li><li><a class="nounderline abstract_t">Levy RV, Brathwaite KE, Sarathy H, et al. Analysis of Active and Passive Tobacco Exposures and Blood Pressure in US Children and Adolescents. JAMA Netw Open 2021; 4:e2037936.</a></li><li><a class="nounderline abstract_t">Merrick MT, Ford DC, Ports KA, et al. Vital Signs: Estimated Proportion of Adult Health Problems Attributable to Adverse Childhood Experiences and Implications for Prevention - 25 States, 2015-2017. MMWR Morb Mortal Wkly Rep 2019; 68:999.</a></li><li><a class="nounderline abstract_t">Suglia SF, Sapra KJ, Koenen KC. Violence and cardiovascular health: a systematic review. Am J Prev Med 2015; 48:205.</a></li><li><a class="nounderline abstract_t">Su S, Wang X, Pollock JS, et al. Adverse childhood experiences and blood pressure trajectories from childhood to young adulthood: the Georgia stress and Heart study. Circulation 2015; 131:1674.</a></li><li><a class="nounderline abstract_t">Vieux R, Gerard M, Roussel A, et al. Kidneys in 5-year-old preterm-born children: a longitudinal cohort monitoring of renal function. Pediatr Res 2017; 82:979.</a></li><li><a class="nounderline abstract_t">South AM, Shaltout HA, Washburn LK, et al. Fetal programming and the angiotensin-(1-7) axis: a review of the experimental and clinical data. Clin Sci (Lond) 2019; 133:55.</a></li><li><a class="nounderline abstract_t">Davis EF, Lazdam M, Lewandowski AJ, et al. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics 2012; 129:e1552.</a></li><li><a class="nounderline abstract_t">Flynn JT, Ng DK, Chan GJ, et al. The effect of abnormal birth history on ambulatory blood pressure and disease progression in children with chronic kidney disease. J Pediatr 2014; 165:154.</a></li><li><a class="nounderline abstract_t">Jung FF, Ingelfinger JR. Hypertension in childhood and adolescence. Pediatr Rev 1993; 14:169.</a></li><li><a class="nounderline abstract_t">Niiranen TJ, McCabe EL, Larson MG, et al. Heritability and risks associated with early onset hypertension: multigenerational, prospective analysis in the Framingham Heart Study. BMJ 2017; 357:j1949.</a></li><li><a class="nounderline abstract_t">Hunt SC, Ellison RC, Atwood LD, et al. Genome scans for blood pressure and hypertension: the National Heart, Lung, and Blood Institute Family Heart Study. Hypertension 2002; 40:1.</a></li><li class="breakAll">Kaplan NM. Primary hypertension: Pathogenesis. In: Kaplan's Clinical Hypertension, 8th ed, Kaplan NM (Ed), Lippincott Williams &amp; Wilkins, Philadelphia 2002. p.58.</li><li class="breakAll">Ward R. Familial aggregation and genetic epidemiology of blood pressure. In: Hypertension: Pathophysiology, Diagnosis and Management, Laragh J, Brenner B (Eds), Raven Press, New York 1990. p.81.</li><li><a class="nounderline abstract_t">Havlik RJ, Feinleib M. Epidemiology and genetics of hypertension. Hypertension 1982; 4:III121.</a></li><li><a class="nounderline abstract_t">Biron P, Mongeau JG, Bertrand D. Familial aggregation of blood pressure in 558 adopted children. Can Med Assoc J 1976; 115:773.</a></li><li><a class="nounderline abstract_t">Annest JL, Sing CF, Biron P, Mongeau JG. Familial aggregation of blood pressure and weight in adoptive families. II. Estimation of the relative contributions of genetic and common environmental factors to blood pressure correlations between family members. Am J Epidemiol 1979; 110:492.</a></li><li class="breakAll">Christian JC. Twin studies of blood pressure. In: Children's Blood Pressure, Report of the 85th Ross Conference on Pediatric Research, 1985. p.51.</li><li class="breakAll">Feinleib M, Garrison R, Borhani N, et al. Studies of hypertension in twins. In: Epidemiology and Control of Hypertension, Paul 0 (Ed), Stratton Intercontinental Medical Book Corp, New York 1975. p.3.</li><li><a class="nounderline abstract_t">Muntner P, He J, Cutler JA, et al. Trends in blood pressure among children and adolescents. JAMA 2004; 291:2107.</a></li><li><a class="nounderline abstract_t">Obarzanek E, Wu CO, Cutler JA, et al. Prevalence and incidence of hypertension in adolescent girls. J Pediatr 2010; 157:461.</a></li><li><a class="nounderline abstract_t">Cheung EL, Bell CS, Samuel JP, et al. Race and obesity in adolescent hypertension. Pediatrics 2017; 139.</a></li><li><a class="nounderline abstract_t">Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25:305.</a></li><li><a class="nounderline abstract_t">Welch WP, Yang W, Taylor-Zapata P, Flynn JT. Antihypertensive drug use by children: are the drugs labeled and indicated? J Clin Hypertens (Greenwich) 2012; 14:388.</a></li><li><a class="nounderline abstract_t">Wyszyńska T, Cichocka E, Wieteska-Klimczak A, et al. A single pediatric center experience with 1025 children with hypertension. Acta Paediatr 1992; 81:244.</a></li><li><a class="nounderline abstract_t">Arar MY, Hogg RJ, Arant BS Jr, Seikaly MG. Etiology of sustained hypertension in children in the southwestern United States. Pediatr Nephrol 1994; 8:186.</a></li><li><a class="nounderline abstract_t">Nugent JT, Young C, Funaro MC, et al. Prevalence of Secondary Hypertension in Otherwise Healthy Youths with a New Diagnosis of Hypertension: A Meta-Analysis. J Pediatr 2022; 244:30.</a></li><li><a class="nounderline abstract_t">Chen Y, Ye P, Dong H, et al. Clinical characteristics of pediatric hypertension: a multicenter study in China. J Hypertens 2023; 41:1753.</a></li><li><a class="nounderline abstract_t">Dillon MJ. The diagnosis of renovascular disease. Pediatr Nephrol 1997; 11:366.</a></li><li><a class="nounderline abstract_t">Deal JE, Snell MF, Barratt TM, Dillon MJ. Renovascular disease in childhood. J Pediatr 1992; 121:378.</a></li><li><a class="nounderline abstract_t">Piercy KT, Hundley JC, Stafford JM, et al. Renovascular disease in children and adolescents. J Vasc Surg 2005; 41:973.</a></li><li><a class="nounderline abstract_t">Obrycki Ł, Sarnecki J, Sobczyk K, et al. High prevalence of extrarenal artery involvement in children with fibromuscular dysplasia - a single-center experience. J Hypertens 2021; 39:2439.</a></li><li><a class="nounderline abstract_t">Fossali E, Signorini E, Intermite RC, et al. Renovascular disease and hypertension in children with neurofibromatosis. Pediatr Nephrol 2000; 14:806.</a></li></ol></div><div id="topicVersionRevision">Topic 6111 Version 60.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28827377" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35603599" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Ambulatory Blood Pressure Monitoring in Children and Adolescents: 2022 Update: A Scientific Statement From the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7512490" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : White coat hypertension and related phenomena. A clinical approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30571565" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : White Coat Hypertension in Children and Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8406652" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Cardiovascular reactivity to stress predicts future blood pressure status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28814425" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Hypertension outcomes and cardiovascular status in young adults with childhood-diagnosed white coat hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30001558" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Hypertension Among Youths - United States, 2001-2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33792732" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Trends in Blood Pressure and Hypertension Among US Children and Adolescents, 1999-2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31589252" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Global Prevalence of Hypertension in Children: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29710187" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Prevalence and Severity of High Blood Pressure Among Children Based on the 2017 American Academy of Pediatrics Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30571555" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Prevalence of Hypertension in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30044314" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Updates to pediatric hypertension guidelines: influence on classification of high blood pressure in children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30778829" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The population-based prevalence of hypertension and correlates of blood pressure among Australian children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30817454" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Impact of the 2017 Blood Pressure Guidelines by the American Academy of Pediatrics in overweight/obese youth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31688292" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Impact of ESH and AAP hypertension guidelines for children and adolescents on office and ambulatory blood pressure-based classifications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31630571" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Impact of the 2017 American Academy of Pediatrics Guideline on Hypertension Prevalence Compared With the Fourth Report in an International Cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29976572" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Clinical Implications of the Revised AAP Pediatric Hypertension Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17846287" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : High blood pressure trends in children and adolescents in national surveys, 1963 to 2002.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23856492" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Childhood blood pressure trends and risk factors for high blood pressure: the NHANES experience 1988-2008.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16740849" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Prevalence of abnormal lipid and blood pressure values among an ethnically diverse population of eighth-grade adolescents and screening implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26908707" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Change in Weight Status and Development of Hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17145992" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Emergence of sex differences in prevalence of high systolic blood pressure: analysis of a longitudinal adolescent cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27045117" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Is the prevalence of hypertension in overweight children overestimated?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22665416" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Secular trends in BMI and blood pressure among children and adolescents: the Bogalusa Heart Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16492428" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The relationship of body mass index and blood pressure in primary care pediatric patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18035150" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Size at birth, infant growth, and blood pressure at three years of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29358459" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Determinants of Cardiometabolic Risk Factors in the First Decade of Life: A Longitudinal Study Starting at Birth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16061601" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Effect of obesity and high blood pressure on plasma lipid levels in children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30489016" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Sodium intake and blood pressure in children with clinical conditions: A systematic review with meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24384690" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : A 4-year prospective follow-up study of childhood OSA and its association with BP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34404224" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Sleep-Disordered Breathing and Cardiovascular Disease in Children and Adolescents: A Scientific Statement From the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24239497" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Long-term changes in blood pressure control in elementary school-aged children with sleep-disordered breathing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25953912" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Blood pressure after surgery among obese and nonobese children with obstructive sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30668275" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Effect of Adenotonsillectomy on Ambulatory Blood Pressure in Pediatric Obstructive Sleep Apnea: 6-Month Follow-up Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22337681" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Moderate to vigorous physical activity and sedentary time and cardiometabolic risk factors in children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36994715" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Pediatric Primary Hypertension: An Underrecognized Condition: A Scientific Statement From the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34293838" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Effects of aerobic exercise on obese children with metabolic syndrome: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14993142" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Does breast-feeding in infancy lower blood pressure in childhood? The Avon Longitudinal Study of Parents and Children (ALSPAC).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9451261" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Relation of infant diet to childhood health: seven year follow up of cohort of children in Dundee infant feeding study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15477400" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Associations of parental, birth, and early life characteristics with systolic blood pressure at 5 years of age: findings from the Mater-University study of pregnancy and its outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33620445" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Analysis of Active and Passive Tobacco Exposures and Blood Pressure in US Children and Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31697656" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Vital Signs: Estimated Proportion of Adult Health Problems Attributable to Adverse Childhood Experiences and Implications for Prevention - 25 States, 2015-2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25599905" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Violence and cardiovascular health: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25858196" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Adverse childhood experiences and blood pressure trajectories from childhood to young adulthood: the Georgia stress and Heart study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28665930" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Kidneys in 5-year-old preterm-born children: a longitudinal cohort monitoring of renal function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30622158" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Fetal programming and the angiotensin-(1-7) axis: a review of the experimental and clinical data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22614768" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24698454" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : The effect of abnormal birth history on ambulatory blood pressure and disease progression in children with chronic kidney disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8493186" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Hypertension in childhood and adolescence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28500036" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Heritability and risks associated with early onset hypertension: multigenerational, prospective analysis in the Framingham Heart Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12105129" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Genome scans for blood pressure and hypertension: the National Heart, Lung, and Blood Institute Family Heart Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12105129" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Genome scans for blood pressure and hypertension: the National Heart, Lung, and Blood Institute Family Heart Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12105129" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Genome scans for blood pressure and hypertension: the National Heart, Lung, and Blood Institute Family Heart Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7049926" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Epidemiology and genetics of hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/974967" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Familial aggregation of blood pressure in 558 adopted children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/507040" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Familial aggregation of blood pressure and weight in adoptive families. II. Estimation of the relative contributions of genetic and common environmental factors to blood pressure correlations between family members.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/507040" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Familial aggregation of blood pressure and weight in adoptive families. II. Estimation of the relative contributions of genetic and common environmental factors to blood pressure correlations between family members.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/507040" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Familial aggregation of blood pressure and weight in adoptive families. II. Estimation of the relative contributions of genetic and common environmental factors to blood pressure correlations between family members.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15126439" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Trends in blood pressure among children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20488454" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Prevalence and incidence of hypertension in adolescent girls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Race and obesity in adolescent hypertension</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7875754" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22672093" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Antihypertensive drug use by children: are the drugs labeled and indicated?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1511199" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : A single pediatric center experience with 1025 children with hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8018497" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Etiology of sustained hypertension in children in the southwestern United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35120981" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Prevalence of Secondary Hypertension in Otherwise Healthy Youths with a New Diagnosis of Hypertension: A Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37602486" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Clinical characteristics of pediatric hypertension: a multicenter study in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9203196" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : The diagnosis of renovascular disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1517911" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Renovascular disease in childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15944596" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Renovascular disease in children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34516057" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : High prevalence of extrarenal artery involvement in children with fibromuscular dysplasia - a single-center experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10955932" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Renovascular disease and hypertension in children with neurofibromatosis.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
